Recombinant expression a novel fibronectin-collage fusion peptide modulating stem cell stemness via integrin β3.
Ontology highlight
ABSTRACT: Constructing bionic extracellular matrix (ECM) is an attractive proposition for tissue engineering and clinical regeneration therapy involving the stemness of stem cells. Here, a novel recombinant protein fibronectin-collagen peptide (FCP) was designed to modulate the function of ECM expressed by Picha. pastoris strain X33. This FCP promotes cell migration and adhesion and maintains rBMSC stemness by binding integrin β3. Its effects were blocked by both integrin β3 siRNA and the integrin β3 inhibitor Cilengitide. A template-independent ab initio prediction modeling approach is the best approach to construct a stable FCP protein model, which predicts the binding sites between FCP and integrin β3. FCP may be used in the in vitro culture and clinical regeneration of stem cells that highly exp
SUBMITTER: Luo X
PROVIDER: S-EPMC9151557 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature
ACCESS DATA